Lactobacillus casei secreting α-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb/c mice

Journal of Microbiology and Biotechnology

Volumn 18, Issue 12, 2008, Pages 1975-1983

  Yoon, Sun Woo ^a   Lee, Chul Ho ^a   Kim, Jeong Yoon ^b   Kim, Jie Youn ^c   Sung, Moon Hee ^c,d   Poo, Haryoung ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Bioleaders Corporation   (South Korea)

^d Kookmin University   (South Korea)

Author keywords

MSH; Cytokine production; IBD; Lactobacillus casei

Indexed keywords

ALPHA INTERMEDIN; CYTOKINE; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTOBACILLUS CASEI EXTRACT; MYELOPEROXIDASE; INTERLEUKIN DERIVATIVE; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; MORTALITY; MOUSE; NONHUMAN; SURVIVAL RATE; WEIGHT REDUCTION; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; COLON; ENTERITIS; GENETICS; IMMUNOLOGY; LACTOBACILLUS CASEI; METABOLISM; MOLECULAR CLONING; PATHOLOGY;

LACTOBACILLUS CASEI; MURINAE; MUS; STREPTOCOCCUS BOVIS;

ACUTE DISEASE; ALPHA-MSH; ANIMALS; CLONING, MOLECULAR; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; LACTOBACILLUS CASEI; MICE; MICE, INBRED BALB C; NF-KAPPA B; PROBIOTICS;

EID: 67651008822     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0800.445     Document Type: Article

References (39)

1. Bantel, H., C. Berg, M. Vieth, M. Stolte, W. Kruis, and K. Schulze-Osthoff. 2000. Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am. J. Gastroenterol. 95: 3452-3457.
2. Barbara, G., Z. Xing, C. M. Hogaboam, J. Gauldie, and S. M. Collins. 2000. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 46: 344-349.
3. Bhardwaj, R. S., A. Schwarz, E. Becher, K. Mahnke, Y. Aragane, T. Schwarz, and T. A. Luger. 1996. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J. Immunol. 156: 2517-2521.
4. Blumberg, R. S., L. J. Saubermann, and W. Strober. 1999. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11: 648-656.
5. Borruel, N., M. Carol, F. Casellas, M. Antolín, F. de Lara, E. Espín, J. Naval, F. Guarner, and J. R. Malagelada. 2002. Increased mucosal tumor necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51: 659-664.
6. Catania, A., V. Gerloni, S. Procaccia, L. Airaghi, M. G. Manfredi, C. Lomater, L. Grossi, and J. M. Lipton. 1994. The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: Comparisons with other anticytokine molecules. Neuroimmunomodulation 1: 321-328.
7. Catania, A. and J. M. Lipton. 1993. Alpha-Melanocyte stimulating hormone in the modulation of host reactions. Endocr. Rev. 14: 564-576.
8. Colombo, G., R. Buffa, M. T. Bardella, L. Garofalo, A. Carlin, J. M. Lipton, and A. Catania. 2002-2003. Anti-inflammatory effects of alpha-melanocyte stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 10: 208-216.
9. Cotta, M. A. and T. R. Whitehead. 1993. Regulation and cloning of the gene encoding amylase activity of the ruminal bacterium Streptococcus bovis. Appl. Environ. Microbiol. 59: 189-196.
10. Dieleman, L. A., M. S. Goerres, A. Arends, D. Sprengers, C. Torrice, F. Hoentjen, W. B. Grenther, and R. B. Sartor. 2003. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52: 370-376.
11. Dubertret, L., C. Lebreton, and R. Touraine. 1982. Neutrophil studies in psoriatics: In vivo migration, phagocytosis and bacterial killing. J. Invest. Dermatol. 79: 74-78.
12. Fichtner-Feigl, S., I. J. Fuss, J. C. Preiss, W. Strober, and A. Kitani. 2005. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. J. Clin. Invest. 115: 3057-3071.
13. Gantz, I., Y. Konda, T. Tashiro, Y. Shimoto, H. Miwa, G. Munzert, S. J. Watson, J. DelValle, and T. Yamada. 1993. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268: 8246-8250.
14. Gonzalez-Rey, E., N. Varela, A. F. Sheibanie, A. Chorny, D. Ganea, and M. Delgado. 2006. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 103: 4228-4233.
15. Hogaboam, C. M., B. A. Vallance, A. Kumar, C. L. Addison, F. L. Graham, J. Gauldie, and S. M. Collins. 1997. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J. Clin. Invest. 100: 2766-2776.
16. Karin, M. and A. Lin. 2002. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3: 221-227.
17. Kojouharoff, G., W. Hans, F. Obermeier, D. N. Männel, T. Andus, J. Schölmerich, V. Gross, and W. Falk. 1997. Neutralization of tumor necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulfate sodium-induced colitis in mice. Clin. Exp. Immunol. 107: 353-358.
18. Krieglstein, C. F., W. H. Cerwinka, A. G. Sprague, F. S. Laroux, M. B. Grisham, V. E. Koteliansky, N. Senninger, D. N. Granger, and A. R. de Fougerolles. 2002. Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. J. Clin. Invest. 110: 1773-1782.
19. Lee, J. S., H. Poo, D. P. Han, S. P. Hong, K. Kim, M. W. Cho, E. Kim, M. H. Sung, and C. J. Kim. 2006. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J. Virol. 80: 4079-4087.
20. Lipton, J. M., H. Zhao, T. Ichiyama, G. S. Barsh, and A. Catania. 1999. Mechanisms of anti-inflammatory action of alpha-MSH peptides: In vivo and in vitro evidence. Ann. N.Y. Acad. Sci. 885: 173-182.
21. Luger, T. A., T. Brzoska, T. E. Scholzen, D. H. Kalden, C. Sunderkotter, C. Armstrong, and J. Ansel. 2000. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann. N.Y. Acad. Sci. 917: 232-238.
22. 1R in experimental colitis. Gut 55: 1415-1422.
23. Matsumoto, S., T. Hara, T. Hori, K. Mitsuyama, M. Nagaoka, N. Tomiyasu, A. Suzuki, and M. Sata. 2005. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 140: 417-426.
24. Mimura, T., F. Rizzello, U. Helwig, G. Poggioli, S. Schreiber, et al. 2004. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-114.
25. Narita, J., K. Okano, T. Kitao, S. Ishida, T. Sewaki, M. H. Sung, H. Fukuda, and A. Kondo. 2006. Display of alpha-amylase on the surface of Lactobacillus casei cells by use of the PgsA anchor protein, and production of lactic acid from starch. Appl. Environ. Microbiol. 72: 269-275.
26. Okayasu. I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702.
27. Oktar, B. K., F. Ercan, B. C. Yegen, and I. Alican. 2000. The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21: 1271-1277.
28. Papadakis, K. A. and S. R. Targan. 2000. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51: 289-298.
29. Podolsky, D. K. 1991. Inflammatory bowel disease. N. Engl. J. Med. 325: 928-937.
30. Rajora, N., G. Boccoli, D. Burns, S. Sharma, A. P. Catania, and J. M. Lipton. 1997. Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J. Neurosci. 17: 2181-2186.
31. Rajora, N., G. Boccoli, A. Catania, and J. M. Lipton. 1997. Alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18: 381-385.
32. Schultz, M., C. Veltkamp, L. A. Dieleman, W. B. Grenther, P. B. Wyrick, S. L. Tonkonogy, and R. B. Sartor. 2002. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 82: 71-80.
33. Seegers, J. F. 2002. Lactobacilli as live vaccine delivery vectors: Progress and prospects. Trends Biotechnol. 20: 508-515.
34. Shanahan, F. 2001. Probiotics in inflammatory bowel disease. Gut 48: 609.
35. Siegmund, B., F. Rieder, S. Albrich, K. Wolf, C. Bidlingmaier, G. S. Firestein, et al. 2001. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J. Pharmacol. Exp. Ther. 296: 99-105.
36. Steidler, L., W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, W. Fiers, and E. Remaut. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352-1355.
37. Tien, M. T., S. E. Girardin, B. Regnault, L. Le Bourhis, M. A. Dillies, J. Y. Coppée, R. Bourdet-Sicard, P. J. Sansonetti, and T. Pédron. 2006. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 176: 1228-1237.
38. Vowinkel, T., T. J. Kalogeris, M. Mori, C. F. Krieglstein, and D. N. Granger. 2004. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig. Dis. Sci. 49: 556-564.
39. Vowinkel, T., M. Mori, C. F. Krieglstein, J. Russell, F. Saijo, S. Bharwani, et al. 2004. Apolipoprotein A-IV inhibits experimental colitis. J. Clin. Invest. 114: 260-269.